Header Logo

Connection

MICHELLE A FANALE to Intention to Treat Analysis

Back to Details
This is a "connection" page, showing publications MICHELLE A FANALE has written about Intention to Treat Analysis.
MICHELLE A FANALE
Connection Strength
0.040
Intention to Treat Analysis
  1. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019 01 19; 393(10168):229-240.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.